K. Donegan

First name
K.
Last name
Donegan
Donegan, K., Beau-Lejdstrom, R., King, B., Seabroke, S., Thomson, A., & Bryan, P. (2013). Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK. Vaccine. http://doi.org/10.1016/j.vaccine.2013.08.024
Donegan, K., King, B., & Bryan, P. (2014). Safety of pertussis vaccination in pregnant women in UK: observational study. Bmj. http://doi.org/10.1136/bmj.g4219
Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Donegan, K., et al. (2014). Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. http://doi.org/10.1016/s0140-6736(14)60686-3
Stowe, J., Andrews, N., Kosky, C., Dennis, G., Eriksson, S., Hall, A., et al. (2016). Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England. Sleep. http://doi.org/10.5665/sleep.5752
Donegan, K., Fox, N., Black, N., Livingston, G., Banerjee, S., & Burns, A. (2017). Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study. Lancet Public Health. http://doi.org/10.1016/s2468-2667(17)30031-2
Datta-Nemdharry, P., Thomson, A., Beynon, J., & Donegan, K. (2017). Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4092
Allen, C., & Donegan, K. (2017). The impact of regulatory action on the co-prescribing of renin-angiotensin system blockers in UK primary care. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4219
Wong, J., Donegan, K., Seabroke, S., & Bryan, P. (2017). Evaluation of compliance to the timing of childhood vaccinations following introduction of the meningococcal B vaccine in the UK. Drug Safety.
Bryan, P., Seabroke, S., Wong, J., Donegan, K., Webb, E., Goldsmith, C., et al. (2018). Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study. Lancet Child Adolesc Health. http://doi.org/10.1016/s2352-4642(18)30103-2
Donegan, K., Owen, R., Bird, H., Burch, B., Smith, A., & Tregunno, P. (2018). Exploring the Potential Routine Use of Electronic Healthcare Record Data to Strengthen Early Signal Assessment in UK Medicines Regulation: Proof-of-Concept Study. Drug Saf. http://doi.org/10.1007/s40264-018-0675-x